Work

Figure S3 from Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Anti-Tumor Activity Against Prostaglandin-Expressing Tumors

Year: 2023
Type: other
Abstract: Combination of Single EP2 and EP4 antagonism mirrors dual antagonism by TPST-1495
Language: English
Subfield: Pharmacology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4384200252
Cites:
Cited by:
Related to: 10